ProcureCon Pharma US 2017

October 24-October 26, 2017

Westin Philadelphia, PA

Contact Us: 1.888.482.6012

Day 2: Pro-Collaboration One World, The Ultimate Goal: Excelling As A Unified Procurement Function

07:15 AM - 07:20 AM Women In Procurement Breakfast

Women bring a different perspective to procurement and supply chain management and are increasingly becoming an integral part of many supply chain organizations. The ever-popular ProcureCon Women in Procurement Breakfast returns to provide an intimate setting for executives to discuss the challenges women in procurement face and celebrate their successes. Participation provides you with access to a growing network of peers you can connect with throughout the year.

07:20 AM - 08:20 AM Continental Breakfast & Registration

08:20 AM - 08:25 AM Welcome Remarks

Jenna Williams, Program Director, ProcureCon Pharma


Jenna Williams

Program Director
ProcureCon Pharma

08:25 AM - 08:35 AM Chairperson’s Opening Address

Dr. Elizabeth Iorns, Founder & CEO, Science Exchange


Dr. Elizabeth Iorns

Founder & CEO
Science Exchange

08:35 AM - 09:00 AM Presentation: Corporate Culture: Cure or Culprit - Fostering Collaboration

Laurin Vincent, Global Alliance Leader, Genentech
Relationship Management is the only way to access the needed value from Pharma & CRO partnerships. When we approach relationship management from the lens of Cooperation, we are disadvantaged to reach true breakthroughs, as these only come from Collaboration.

Describe the difference between Cooperation and Collaboration and why it matters.

• How we can measure the success of partnerships with external providers
• The role of procurement in driving effective strategic relationship management principles
• The mindset shift required in order to truly deliver breakthroughs for your organization with external providers and business partners


Laurin Vincent

Global Alliance Leader
The geographic footprint of research and development has widened to encompass new technologies and innovators from emerging places. Through the Innovation Hub, there has been much significance in accelerating the rate at which product design, clinical validation, commercialization and market development have been developed, introduced, and scaled to meet the needs of people in resource-limited communities. Using a product development partnership model, discover how Merck & Co., inc. bring together the best minds from across public and private sectors to solve the world’s leading health problems.
•Capitalizing on regional Innovation Hubs to deliver innovation & speed
•Understanding the value proposition procurement provides through speed to market, risk mitigation and molding more effective partnering with the scientists
•Learn what decisions need to be made to create organizational flexibility to support the changing R&D landscape
•Structure efficiency and flexibility in mapping product supply during early preclinical stages
•Identify relevant facts that are required to accurately predict and scale up supply needs and conduct the planning work necessary, sustainable commercialization
•Align multiple functions to ensure scales up & effective R&D support


Moushmi Culver

AVP, Global Lead for Research & Development Sourcing & Procurement
Merck & Co., Inc.

Adam Randall

Director, R&D Sourcing & Procurement
Merck & Co., Inc.
Clearly, the global pharmaceutical industry is undergoing a major consolidation phase. Behind the stated objectives of access to new drugs, cost savings and synergies is a drive to focus on core competencies. Looking at procurement to guard against overpaying and facilitating poor post-merger integration, what are the best practices to fully:

Contract consolidation & merging of policies best practices
Leverage resources from big pharma and determine processes that align/tactfully scale down overlapping resources
Work on commercialization initiatives & the process behind divestures
Facilitate total creation & collaboration
Bridge communication & building stronger relationships under pressure
Support transitioning scientists


Chantal Sarmanoukian

Executive Director, Head of Strategic Procurement,
AMAG Pharmaceuticals

Karen Fedele

Head of Integrated Procurement Solutions

Dr. Elizabeth Iorns

Founder & CEO
Science Exchange

Joseph Richardson

President & CEO
Professional Purchasing Partners

Vishal Bhandari

A.T. Kearney

10:20 AM - 11:00 AM Morning Refreshment & Networking Break In The Solutions Zone

11:00 AM - 11:40 AM Case Study Interactive: Category Strategy To Innovative Gurus: The Leaders Who Revolutionize SRM

Sean Cumbie, Head of Procurement & Global Biotech, AstraZeneca
The important difference in global category management is that all practitioners have distinct functionality profiles that are called upon to drive the operation of their teams, whether it’s tactical or task organizers. Furthermore, these differences in execution may also allow for opportunities to implement innovation into your supplier bases and new strategic measures for supplier diversity. Create the Innovation Tool Box to diagnose, task, drive, execute and score a healthy and proactive supplier base. Curious points include how to manage your supplier engagements in practice and ensure corporate protocol: how do you receive supplier ideas, how are other functions engaged, how do you staff the project team? How do you liaise between the supplier and the internal departments to enable supplier buy in as well?
Be hands on with the content and interact with the experts and to tool box best practices for:

• Obtaining the right mix of data to benchmark
• Crafting mutually beneficial supplier scorecards and cross functional performance assessments to measure performance against your SOW and the cadence to receiving those reports
• Quantifying innovation and elevating strategic partnerships to equip suppliers as the MVP’s of the team (particularly when needing to expedite demand change or maintain supplier continuity)
• When innovation calls for supplier diversity
• Creating a shared services function to leverage spend and ensure only one person or team is negotiating with your suppliers- effectively communicating strategic directive


Sean Cumbie

Head of Procurement & Global Biotech

11:40 AM - 12:00 PM Supplier Relationship Management: Industry Benchmarking Report on Evolution of Effective SRM Practices

Shreyas Murthi, Principal, ZS Associates
Supplier Relationship Management (SRM) has been touted as an enabler and driver for the triple aim of spend management, improving efficiency, and driving innovation/creating value. Many organizations have developed innovative approaches to SRM and started to realize many benefits; however, there is wide variation across the industry and best practices and effective approaches are still early in development.

As part of the second wave of the bi-annual industry benchmarking study, this session will share key trends in how SRM is being implemented across the pharmaceutical industry and its evolution over time, including:
· Perspectives on how SRM is being implemented across the industry and its evolution in the last 2-3 years
· Best practices organizations have adopted to make SRM successful
· Best practices around structuring and managing SRM relationships globally and across affiliates


Shreyas Murthi

ZS Associates

12:00 PM - 12:20 PM Supplier Relationship Management: Case Study – Bringing Value and Innovation via a Successful SRM Journey

Jennifer Sadr, Head of Prof Services, US. Commercial Services, Global Pharma Procurement, Genentech Shreyas Murthi, Principal, ZS Associates
Although many procurement organization recognize the value of Supplier Relationship Management and are beginning their journey, establishing and nurturing a successful SRM program is quite challenging.
This session will provide insight into the journey of how Genentech / Roche has engaged in a successful SRM relationship with a key vendor, and include:
· Journey of Genentech / Roche’s SRM program with a key vendor over the last three years
· Successes and challenges of creating a win-win relationship along the journey
· Driving innovation within the organization by leveraging Vendor’s capabilities
· Some key learnings and best practices which other pharma procurement groups can benefit from


Jennifer Sadr

Head of Prof Services, US. Commercial Services, Global Pharma Procurement

Shreyas Murthi

ZS Associates
Pharmaceutical companies and their suppliers face an increasingly challenging operating environment, marked by industry-wide restructuring, slowing revenue growth, constrained profits, competition from companies in emerging markets, and uncertainty in overall macroeconomic conditions. In light of these issues, innovation, as a means of creating business value and generating growth, is crucial for pharmaceutical companies and suppliers alike. How to cultivate innovation, implement it, and sustain it requires building more collaborative relationships with your key suppliers. Discuss how to further develop your supplier relationships and bring them into the process to help grow your company’s revenue and profit. Address:
•Overcoming ‘traditional’ buyer-supplier attitudes and perceptions of limited information sharing, trust, capabilities and understanding of partner needs
•Navigating your single sourcing strategy for privileged access to supplier innovation
•Giving your critical suppliers a seat at the table and partnering for value creation


Vincent Djuhadi

Director, Development And Sourcing, Discovery and Product Development
Teva Global R&D

Steven Cray

Director of Supplier Relationship Management

Rea Tachdjian

Procurement Management | Global Strategic Sourcing | Category Partner | Supplier Management
University of South Florida

John Ure

Senior Director Commercials & Corporate Procurement

Christopher Ianelli

Founder & CEO

Dr. Elizabeth Iorns

Founder & CEO
Science Exchange

Mark A. Lanfear

Vice President and Global Practice Lead, Life Sciences Solutions
Kelly Outsourcing and Consulting Group

1:00 PM - 2:00 PM Lunch

2:00 PM - 3:00 PM Workshop: “Preparing For The Worst”: Leadership In The Face of Major Supply Chain Disruptions: Differentiating between Baseline And Contextual Traits

Arash Azadegan, Associate Professor of Supply Chain Management, Rutgers Business School Iana Shaheen, Ph.D. Candidate, University of South Florida
Most of Pharma knows that a third-party incident can cost them dearly, but few realize just by how much. In terms of downside losses, there are several ways in which companies can incur unnecessary expenses, expose themselves to fines, or be held responsible for restitution, not to mention the opportunity costs associated with not being able to serve existing customers or to pursue new business in the wake of a disruptive event. However, one of the more prominent and more costly risks associated with third parties is regulatory non-compliance. This pressure is unlikely to ease anytime soon since regulatory scrutiny and associated life and industry endangerment are intensifying ramifications in the Pharma and Biotech world. Voice your leadership endorsement when analyzing supply chain disruption and see how you can:

  • Identify what leadership characteristics help companies better respond to supply chain disruptions
  • Clarify whether leadership effectiveness changes during the life-cycle of a supply chain disruption
  • Differentiate response and recovery approaches to different types of disruptions
  • Ultimate goals: business continuity and resiliency


Arash Azadegan

Associate Professor of Supply Chain Management
Rutgers Business School

Iana Shaheen

Ph.D. Candidate
University of South Florida

3:00 PM - 3:30 PM Afternoon Refreshment & Networking Break In The Networking Lounge

Be sure to join these interactive roundtable sessions and take a deep dive into the specific areas you came to discuss. Opportunities to sit and learn from life science executives like these do not exist elsewhere. Take control of your own event experience. Don’t be shy! Ask questions (or answer them!) of other conference attendees who are dealing with the same challenges as you.

1. Network with industry peers with very similar challenges, interests and responsibilities
2. Take a deep dive into a niche topic in an intimate and informal setting moderated by a subject matter expert
3. Don’t miss out on the discussions you want to participate in—you’ll get to select a new topic after 30 minutes

Table 1: Making The Most Of Your Outsourcing Engagements
Lisa Khan, Former Senior Director of Professional Services Procurement, Mylan

Table 2: Supporting The Scientists
Vincent Djuhadi, Director, Development And Sourcing, Discovery and Product Development, Teva Global R&D

Table 3: Exit Strategies: Unwinding Supplier Relationships
Rose Prisco, Senior Manager, Strategic Sourcing, Pacira

Table 4: Elevating Your Procurement Maturity: Exploring New Design Processes For Better Partnerships
Brian Portugal, Senior Director of Purchasing, Lexicon Pharmaceuticals

Table 5: The Patient’s Voice


Brian Portugal

Senior Director of Purchasing
Lexicon Pharmaceuticals

Vincent Djuhadi

Director, Development And Sourcing, Discovery and Product Development
Teva Global R&D

Lisa Khan

Director, Strategic Sourcing, Professional Services & IT
Alexion Pharmaceuticals, Inc.

Rose Prisco

Senior Manager, Strategic Sourcing

4:30 PM - 4:30 PM Conference Concludes

Live Chat Software